UNP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Union Pacific Corp (UNP) is not a strong buy for a beginner investor seeking long-term growth at this moment. While the company shows some positive financial trends and a stable technical setup, the lack of significant positive trading signals, cautious sentiment from Congress trading, and mixed analyst ratings suggest a hold position. Additionally, the pre-market price decline and limited upside potential in the short term do not align with the user's impatient investment approach.
The technical indicators show a neutral to slightly bullish trend. The MACD histogram is positive but contracting, RSI is neutral at 64.731, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 263.328, with resistance at 267.041 and support at 259.615. However, the pre-market price is slightly down (-0.22%), indicating some short-term weakness.
Analysts see potential upside if the freight cycle recovery continues.
The company has shown steady execution and guidance in its Q4 results.
Positive price target revisions from several analysts, including BMO Capital, Citi, and Barclays.
Congress trading data shows a recent sale transaction, indicating cautious sentiment.
Pre-market price is slightly down (-0.22%), and stock trend analysis predicts a potential decline in the short term (-0.73% next day, -2.08% next month).
Mixed analyst ratings, with some downgrades and reduced price targets.
Revenue declined in Q4 2025 (-0.59% YoY), and gross margin dropped (-2.18% YoY).
In Q4 2025, Union Pacific's revenue dropped by 0.59% YoY to $6.085 billion. However, net income increased by 4.88% YoY to $1.848 billion, and EPS rose by 6.87% YoY to $3.11. Gross margin declined by 2.18% YoY to 68.96%. While profitability improved, the revenue decline and gross margin contraction are concerns.
Analysts have mixed views on UNP. Recent price target changes include increases from BMO Capital ($295), Citi ($270), and Barclays ($285), but JPMorgan and TD Cowen lowered their targets. Ratings range from Neutral to Buy, with no strong consensus. Goldman Sachs highlighted concerns about the company's focus on acquisitions over fundamental improvements.
